Oncternal Therapeutics, a leading U.S. oncology company, has announced the dosing of the first patient in a phase 1b trial of its investigational drug cirmtuzumab, used in combination with the standard-of-care chemotherapy drug paclitaxel. This trial marks a significant step in evaluating the potential of cirmtuzumab for treating patients with advanced stages of breast cancer. […]
An all new smart bra dubbed as EVA Smart Bra has been developed by a Mexico teenager that can potentially be a life saver for many women suffering from early stages of breast cancer.
An all new smart bra dubbed as EVA Smart Bra has been developed by a Mexican teenager that can potentially be a life saver for many women suffering from early stages of breast cancer. Julian Rios Cantu, all of just 18 years of age, and the co-founder and CEO of Higia Technologies, has developed the […]
Take a look at the Five Reasons Why You Should Take Off Your Bra Before Sleeping!
Did you ever wonder whether sleeping with your bra on can create problems for you? Then, you are right, experts are advising to take off bra before sleeping in the night as it has the potential to cause many health issues which we will be revealing the Five Reasons Why You Should Take Off Your Bra Before […]
As per the latest research reports, it was found that cannabis oil compounds are capable of killing malignant cells of cancer. Cannabis is used as a food supplement in the Western countries and is sold legally. Cannabis oil for breast cancer treatment Cannabis oil was used by a 69 year old woman for the treatment […]
Lilly’s breast cancer drug, abemaciclib given in combination with fulvestrant has met its primary endpoint of progression-free survival (PFS) in a phase 3 breast cancer trial.
Indianapolis-based pharmaceutical giant Lilly has announced positive outcomes from its phase 3 clinical trial, MONARCH 2, involving its innovative breast cancer treatment, abemaciclib, in combination with fulvestrant. This trial marks a significant advancement in the treatment of hormone-receptor-positive (HR+), human epidermal growth factor receptor 2-negative (HER2-) advanced breast cancer. Groundbreaking Results in Cancer Treatment The […]
Roche breast cancer drug, Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy has been demonstrated in a phase 3 trial to have cut the risk of disease recurrence besides increasing the life span of patients with an aggressive form of early breast cancer.
Roche has announced promising results from the APHINITY trial, a crucial Phase 3 study evaluating Perjeta (pertuzumab) in combination with Herceptin (trastuzumab) and chemotherapy. This drug cocktail has been shown to significantly reduce the risk of disease recurrence and extend the lifespan of patients with an aggressive form of early breast cancer. Groundbreaking Results in […]
The University of Antwerp in Belgium has initiated an innovative clinical trial aimed at mitigating the cognitive deficits associated with breast cancer treatment, marking a significant advancement in the field. This trial will utilize a video game-based training and assessment tool, scientifically designed by the UK-based My Cognition, which specializes in cognitive health. Addressing Cognitive […]
What is meant by Breast Cancer? Who gets Breast Cancer Mostly? Breast cancer is a cancerous growth deep in the breast tissue. It is most common in women. Less frequently it is also seen in about 1% of cancers occurring in men. Breast cancer is the major cause of death of cancer in women. Because […]